Eagle Pharmaceuticals Statistics
Total Valuation
EGRX has a market cap or net worth of 19.40 million.
| Market Cap | 19.40M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Friday, March 7, 2025.
| Earnings Date | Mar 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EGRX has 13.02 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 13.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 1.17% |
| Float | 10.82M |
Valuation Ratios
The trailing PE ratio is 1.63.
| PE Ratio | 1.63 |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.08 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.16 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | -7.71 |
| Interest Coverage | 6.85 |
Financial Efficiency
Return on equity (ROE) is 4.88% and return on invested capital (ROIC) is 8.46%.
| Return on Equity (ROE) | 4.88% |
| Return on Assets (ROA) | 6.63% |
| Return on Invested Capital (ROIC) | 8.46% |
| Return on Capital Employed (ROCE) | 13.11% |
| Revenue Per Employee | 1.92M |
| Profits Per Employee | 89,164 |
| Employee Count | 134 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.13% in the last 52 weeks. The beta is 0.78, so EGRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -75.13% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 2.72 |
| Relative Strength Index (RSI) | 83.72 |
| Average Volume (20 Days) | 9,628 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 23.10 |
Income Statement
In the last 12 months, EGRX had revenue of 257.55 million and earned 11.95 million in profits. Earnings per share was 0.91.
| Revenue | 257.55M |
| Gross Profit | 179.88M |
| Operating Income | 41.71M |
| Pretax Income | 29.17M |
| Net Income | 11.95M |
| EBITDA | 62.33M |
| EBIT | 41.71M |
| Earnings Per Share (EPS) | 0.91 |
Balance Sheet
The company has 15.35 million in cash and 72.45 million in debt, giving a net cash position of -57.10 million or -4.38 per share.
| Cash & Cash Equivalents | 15.35M |
| Total Debt | 72.45M |
| Net Cash | -57.10M |
| Net Cash Per Share | -4.38 |
| Equity (Book Value) | 252.04M |
| Book Value Per Share | 19.25 |
| Working Capital | 100.62M |
Cash Flow
In the last 12 months, operating cash flow was -9.32 million and capital expenditures -74,000, giving a free cash flow of -9.39 million.
| Operating Cash Flow | -9.32M |
| Capital Expenditures | -74,000 |
| Free Cash Flow | -9.39M |
| FCF Per Share | -0.72 |
Margins
Gross margin is 69.84%, with operating and profit margins of 16.19% and 4.64%.
| Gross Margin | 69.84% |
| Operating Margin | 16.19% |
| Pretax Margin | 11.33% |
| Profit Margin | 4.64% |
| EBITDA Margin | 24.20% |
| EBIT Margin | 16.19% |
| FCF Margin | n/a |
Dividends & Yields
EGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.21% |
| Shareholder Yield | -2.21% |
| Earnings Yield | 61.57% |
| FCF Yield | -48.40% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EGRX has an Altman Z-Score of 3.26.
| Altman Z-Score | 3.26 |
| Piotroski F-Score | n/a |